Cargando…

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling

Detalles Bibliográficos
Autores principales:	Zanoni, Michele, Borges da Silva, Henrique, Adinolfi, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662014/ https://www.ncbi.nlm.nih.gov/pubmed/38023158 http://dx.doi.org/10.3389/fonc.2023.1297152

Ejemplares similares

Emerging roles of purinergic signaling in anti-cancer therapy resistance
por: Zanoni, Michele, et al.
Publicado: (2022)

Editorial: Proteomic and metabolic reprogramming in myeloma cells within the tumor microenvironment
por: Milan, Enrico, et al.
Publicado: (2023)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
por: Gouirand, Victoire, et al.
Publicado: (2018)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021)

Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism
por: Alshahrani, Shadia Hamoud, et al.
Publicado: (2022)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Editorial: Emerging Mechanisms in Purinergic Signaling: From Cell Biology to Therapeutic Perspectives
por: Gomez-Villafuertes, Rosa, et al.
Publicado: (2020)

The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance
por: Zhao, Chunyu, et al.
Publicado: (2022)

Editorial: Tumor Microenvironment and Resistance to Current Therapies
por: Lasfar, Ahmed, et al.
Publicado: (2019)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
por: Wu, Shaojie, et al.
Publicado: (2021)

Purinergic Signaling in Bone
por: Jørgensen, Niklas Rye, et al.
Publicado: (2013)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Purinergic signaling microenvironments: An introduction
por: Schwiebert, Erik M., et al.
Publicado: (2008)

Editorial: Tumor microenvironment signaling networks in pathophysiology and therapeutics
por: Pirini, Francesca, et al.
Publicado: (2022)

Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment
por: Benito-Lopez, Jesus J., et al.
Publicado: (2023)

Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment
por: Bao, Lisha, et al.
Publicado: (2021)

Editorial: Impact of tumor microenvironment on lung cancer
por: Levantini, Elena
Publicado: (2023)

Editorial: Cell Stress, Metabolic Reprogramming, and Cancer
por: Giannattasio, Sergio, et al.
Publicado: (2018)

Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
por: Kaur, Baljinder, et al.
Publicado: (2023)

Editorial: Proteoglycans in the Tumor Microenvironment
por: Brunetti, Jlenia, et al.
Publicado: (2022)

Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy
por: Chaube, Balkrishna, et al.
Publicado: (2023)

Editorial: Purinergic Signaling and Inflammation
por: Yuan, Xiaoyi, et al.
Publicado: (2021)

Editorial: Purinergic signaling and neuroinflammation
por: Assmann, Charles Elias, et al.
Publicado: (2022)

Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
por: Pu, Zhangya, et al.
Publicado: (2022)

Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance
por: Aria, Hamid, et al.
Publicado: (2022)

Editorial: Megakaryocytes as regulators of tumor microenvironments
por: Migliaccio, Anna Rita, et al.
Publicado: (2022)

Editorial: Tumor microenvironment in bladder cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2023)

Editorial: Microenvironment and therapy-resistance in leukemias
por: Friedmann, Rachel, et al.
Publicado: (2023)

Purinergic signaling: Diverse effects and therapeutic potential in cancer
por: Kaur, Jasmeet, et al.
Publicado: (2023)

Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging
por: Podo, Franca, et al.
Publicado: (2017)

Editorial: Tumor Microenvironment: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression
por: Link, Wolfgang, et al.
Publicado: (2021)

Editorial: Purinergic Signaling in Health and Disease
por: Boué-Grabot, Eric, et al.
Publicado: (2020)

Editorial: The effects of chemotherapy towards the tumor microenvironment
por: Abu, Nadiah, et al.
Publicado: (2022)

Editorial: Tumor microenvironment in primary brain cancers
por: Niechi, Ignacio, et al.
Publicado: (2023)

Editorial: Plasticity of immune cells in tumor microenvironment
por: Oksenych, Valentyn
Publicado: (2023)

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors
por: Qu, Chunrun, et al.
Publicado: (2023)

Metabolic Reprogramming During Multidrug Resistance in Leukemias
por: Vidal, Raphael Silveira, et al.
Publicado: (2018)

Understanding metabolic reprogramming in tumor microenvironment
por: Shu, Shaokun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b8bqbk145ant6g3e6074883hd2